Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 2
1950 1
1960 1
1962 1
1963 1
1964 1
1968 3
1969 3
1970 1
1971 1
2005 3
2006 3
2007 2
2008 2
2009 2
2010 3
2011 1
2013 1
2016 3
2019 1
2020 1
2021 1
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study.
Menzies-Gow A, Wechsler ME, Brightling CE, Korn S, Corren J, Israel E, Chupp G, Bednarczyk A, Ponnarambil S, Caveney S, Almqvist G, Gołąbek M, Simonsson L, Lawson K, Bowen K, Colice G; DESTINATION study investigators. Menzies-Gow A, et al. Lancet Respir Med. 2023 May;11(5):425-438. doi: 10.1016/S2213-2600(22)00492-1. Epub 2023 Jan 23. Lancet Respir Med. 2023. PMID: 36702146 Clinical Trial.
Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: A randomized controlled trial.
Corren J, Larson D, Altman MC, Segnitz RM, Avila PC, Greenberger PA, Baroody F, Moss MH, Nelson H, Burbank AJ, Hernandez ML, Peden D, Saini S, Tilles S, Hussain I, Whitehouse D, Qin T, Villarreal M, Sever M, Wheatley LM, Nepom GT, Sanda S; Immune Tolerance Network ITN057AD CATNIP Study Team. Corren J, et al. Among authors: moss mh. J Allergy Clin Immunol. 2023 Jan;151(1):192-201. doi: 10.1016/j.jaci.2022.08.029. Epub 2022 Oct 9. J Allergy Clin Immunol. 2023. PMID: 36223848 Clinical Trial.
Immunotherapy: first do no harm.
Moss MH. Moss MH. Immunol Allergy Clin North Am. 2005 May;25(2):421-39, viii. doi: 10.1016/j.iac.2005.03.006. Immunol Allergy Clin North Am. 2005. PMID: 15878464 Review.
A 2-week medical student curriculum in an outpatient allergy clinic.
Rosenberg DL, Moss MH, Johnson SK, Osman F. Rosenberg DL, et al. Among authors: moss mh. Ann Allergy Asthma Immunol. 2022 Oct;129(4):525-527. doi: 10.1016/j.anai.2022.03.036. Epub 2022 Apr 8. Ann Allergy Asthma Immunol. 2022. PMID: 35398490 Free PMC article. No abstract available.
Real-world dosing of omalizumab for chronic spontaneous urticaria.
McIntyre AP, Viswanathan RK, Moss MH, Mathur SK. McIntyre AP, et al. Among authors: moss mh. Ann Allergy Asthma Immunol. 2020 Feb;124(2):211-212. doi: 10.1016/j.anai.2019.11.028. Epub 2019 Dec 2. Ann Allergy Asthma Immunol. 2020. PMID: 31805358 No abstract available.
Results of a Phase 2b Trial With GB001, a Prostaglandin D2 Receptor 2 Antagonist, in Moderate to Severe Eosinophilic Asthma.
Moss MH, Lugogo NL, Castro M, Hanania NA, Ludwig-Sengpiel A, Saralaya D, Dobek R, Ojanguren I, Vyshnyvetskyy I, Bruey JM, Osterhout R, Tompkins CA, Dittrich K, Raghupathi K, Ortega H; LEDA Investigators. Moss MH, et al. Chest. 2022 Aug;162(2):297-308. doi: 10.1016/j.chest.2022.02.038. Epub 2022 Mar 3. Chest. 2022. PMID: 35248549 Free article. Clinical Trial.
Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial.
Corren J, Saini SS, Gagnon R, Moss MH, Sussman G, Jacobs J, Laws E, Chung ES, Constant T, Sun Y, Maloney J, Hamilton JD, Ruddy M, Wang CQ, O'Brien MP. Corren J, et al. Among authors: moss mh. J Asthma Allergy. 2021 Aug 16;14:1045-1063. doi: 10.2147/JAA.S318892. eCollection 2021. J Asthma Allergy. 2021. PMID: 34429614 Free PMC article.
Safety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma.
Stempel DA, Szefler SJ, Pedersen S, Zeiger RS, Yeakey AM, Lee LA, Liu AH, Mitchell H, Kral KM, Raphiou IH, Prillaman BA, Buaron KS, Yun Kirby S, Pascoe SJ; VESTRI Investigators. Stempel DA, et al. N Engl J Med. 2016 Sep 1;375(9):840-9. doi: 10.1056/NEJMoa1606356. N Engl J Med. 2016. PMID: 27579634 Free article. Clinical Trial.
39 results